Genetic variants of the hemostatic system and development of transplant coronary artery disease

Journal of Heart and Lung Transplantation

Volumn 21, Issue 6, 2002, Pages 629-636

  He, Jian Qing ^a   Gaur, Lakshmi K ^a   Stempien Otero, April ^b   Nelson, Karen ^a   Levy, Wayne C ^b   O'Brien, Kevin D ^b   Bolgiano, Douglas C ^a   Reiner, Alexander P ^b,c  

^a PUGET SOUND BLOOD CENTER   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; BLOOD CLOTTING FACTOR 13; INTEGRIN; LEUCINE; PROTEIN; PROTEIN PAI 1; UNCLASSIFIED DRUG; VALINE;

ADOLESCENT; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL WALL; CELL ADHESION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; DIABETES MELLITUS; DISEASE COURSE; ENDOTHELIUM INJURY; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART TRANSPLANTATION; HEMOSTASIS; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RECIPIENT; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS;

ADOLESCENT; ADULT; AGED; CORONARY DISEASE; FEMALE; GENOTYPE; HEART TRANSPLANTATION; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SURVIVAL RATE; TISSUE DONORS;

EID: 0036286722     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(01)00409-0     Document Type: Article

References (36)

1. Morphologic observations in the epicardial coronary arteries and their surroundings late after cardiac translplantation (allograft vascular disease)
2. Cardiac allograft vasculopathy: A review
3. Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients
4. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients
5. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients
6. Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy
7. Endothelial activation and development of coronary artery disease in transplanted human hearts
8. Hemostatic risk factors and arterial thrombotic disease
9. Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease
10. A), Ko, Bak and Br (HPA-1, 2, 3, 5)
11. 2 integrin) allele frequencies in three North American populations reveals genetic association between nucleotide 807C/T and amino acid 505 Glu/Lys (HPA-5) dimorphisms
12. Systemic screening for genetic polymorphism in human platelet glycoprotein Ibα
13. Mutation in blood coagulation factor V associated with resistance to activated protein C
14. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
15. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity
16. Plasminogen activator inhibitor type 1 and coronary artery disease
17. Increased type I plasminogen activator inhibitor gene expression in atherosclerotic human arteries
18. Plasminogen activator inhibitor-1 in neointima of vein grafts: Its role in reduced fibrinolytic potential and graft failure
19. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice
20. Mechanisms of graft acceptance: Evidence that plasminogen activator controls donor-reactive delayed-type hypersensitivity responses in cardiac allograft acceptor mice
21. PAI-1, obesity, insulin resistance and risk of cardiovascular events
22. Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus
23. Ambient oxygen tension modulates endothelial fibrinolysis
24. Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation
25. Impaired fibrinolysis in cyclosporine-treated renal transplant patients
26. 807T gene polymorphism with nonfatal myocardial infarction in younger patients
27. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: A case-control study
28. 2 gene coding sequence
29. 1 integrin cell-surface collagen receptor
30. 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells
31. 1) I domain functions as a ligand-specific recognition sequence for endothelial cell attachment and spreading: Molecular and functional characterization
32. 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix
33. 1 integrins
34. 1 is associated with increased risk of cardiovascular mortality in high-risk women
35. Association of a common polymorphism in the factor XIII gene with myocardial infarction
36. Origin of neointimal endothelium and α-actin-positive smooth muscle cells in transplant arteriolsclerosis